4 results were returned
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
International law firm Bird & Bird advises Mitsubishi Chemical Advanced Materials (MCAM), a leading global manufacturer of high-performance materials and a business division of Mitsubishi Chemical Corporation, Japan, on ...
Bird & Bird is delighted to announce that we have received an excellent set of results in the 2018 edition of Legal 500: EMEA. As well as 34 top-tier rankings across our EMEA offices, we were recommended in a further ...
We have advised Aphria Deutschland GmbH on its tender for the cultivation, processing and delivery of cannabis for medical purposes.
DEFAULT DEFAULT Most Relevant Alphabetical Chronological Go
REFINE RESULTS: